| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jun AY et al. | Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. | 2014 | Invest New Drugs | pmid:23673814 |
| Hooshmand S et al. | The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. | 2014 | Br. J. Nutr. | pmid:24780728 |
| Shi W et al. | Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. | 2014 | Biosci Trends | pmid:25641178 |
| Park YJ et al. | Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. | 2014 | Lupus | pmid:24531425 |
| Canalis E et al. | Nemo-like kinase regulates postnatal skeletal homeostasis. | 2014 | J. Cell. Physiol. | pmid:24664870 |
| Nogueira AV et al. | Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells. | 2014 | Mediators Inflamm. | pmid:24976684 |
| Candido R | The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney. | 2014 | Curr. Opin. Nephrol. Hypertens. | pmid:24247823 |
| Aksu F et al. | The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris. | 2014 | Kardiol Pol | pmid:24469748 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Liu S et al. | Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. | 2013 Oct-Dec | Hormones (Athens) | pmid:24457406 |
| Chiang PH et al. | Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. | 2013 Oct-Dec | J Cancer Res Ther | pmid:24518712 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Zamora PO et al. | Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. | 2013 Mar-Apr | Int. J. Toxicol. | pmid:23422080 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Glintborg D et al. | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23211475 |
| Nanjundaiah SM et al. | Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. | 2013 Jan-Mar | Int J Immunopathol Pharmacol | pmid:23527707 |
| Guzel S et al. | Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. | 2013 | Diab Vasc Dis Res | pmid:22496403 |
| Tantikanlayaporn D et al. | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. | 2013 | Phytomedicine | pmid:23557993 |
| Rahnama M et al. | Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. | 2013 | J. Interferon Cytokine Res. | pmid:23745763 |
| Danks L and Takayanagi H | Immunology and bone. | 2013 | J. Biochem. | pmid:23750028 |
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Rakic M et al. | Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. | 2013 | Clin Oral Implants Res | pmid:22708989 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Uehara H et al. | Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. | 2013 | Int. J. Oncol. | pmid:23708710 |
| Luo J et al. | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 | Biomed Res Int | pmid:23710436 |
| Zhu Y et al. | Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. | 2013 | J. Cell. Physiol. | pmid:22674471 |
| Silva HC et al. | Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. | 2013 | Bone | pmid:23142805 |
| Sivagurunathan S et al. | Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. | 2013 | J. Mol. Endocrinol. | pmid:23419317 |
| Ai LS et al. | Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo. | 2013 | Int. J. Cancer | pmid:23420490 |
| Koide M et al. | Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. | 2013 | Endocrinology | pmid:23291450 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Panzarini SR et al. | Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth. | 2013 | Dent Traumatol | pmid:22413942 |
| Bauer S et al. | Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. | 2013 | Epilepsy Res. | pmid:23916144 |
| Nile CJ et al. | Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. | 2013 | J. Clin. Periodontol. | pmid:23919740 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Song JF et al. | Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. | 2013 | Genet. Mol. Res. | pmid:24065669 |
| Yu F et al. | Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. | 2013 | Endocr. J. | pmid:24067544 |
| Wu LZ et al. | Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. | 2013 | Int. J. Mol. Med. | pmid:23443505 |
| Mazière C et al. | Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. | 2013 | Biochem. Biophys. Res. Commun. | pmid:24070606 |
| Nishigaki M et al. | β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:23452546 |
| He JY et al. | Sympathetic neuron can promote osteoblast differentiation through BMP signaling pathway. | 2013 | Cell. Signal. | pmid:23454096 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Yu J et al. | Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. | 2013 | Biol Trace Elem Res | pmid:23456427 |
| Lau CP et al. | Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. | 2013 | Connect. Tissue Res. | pmid:24060052 |
| Corrado A et al. | RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. | 2013 | J. Rheumatol. | pmid:23457386 |
| Koluman BU et al. | Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. | 2013 | Clin. Nephrol. | pmid:23458176 |
| Wang J et al. | Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. | 2013 | Med. Hypotheses | pmid:24074896 |
| Kuo PL et al. | MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. | 2013 | Biochim. Biophys. Acta | pmid:23458685 |
| Li F et al. | Effect of parathyroid hormone on experimental tooth movement in rats. | 2013 | Am J Orthod Dentofacial Orthop | pmid:24075660 |
| Asanuma YF et al. | Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. | 2013 | Mod Rheumatol | pmid:22584471 |
| Sato K et al. | RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. | 2013 | Am. J. Pathol. | pmid:23499553 |
| Sooampon S et al. | Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. | 2013 | J. Periodont. Res. | pmid:22587561 |
| Matuszewski Å et al. | Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. | 2013 | Int Orthop | pmid:23503639 |
| Galli C et al. | GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. | 2013 | Clin Oral Implants Res | pmid:22626030 |
| Gordin D et al. | Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. | 2013 | Diabetes Care | pmid:23801795 |
| Fu YX et al. | Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. | 2013 | J. Vet. Sci. | pmid:23820214 |
| Baud'huin M et al. | Osteoprotegerin: multiple partners for multiple functions. | 2013 | Cytokine Growth Factor Rev. | pmid:23827649 |
| Wang Q et al. | The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. | 2013 | Int. Immunopharmacol. | pmid:23856613 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Zappitelli T et al. | The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. | 2013 | J. Bone Miner. Res. | pmid:23606335 |
| Kao SY et al. | Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. | 2013 | Neurobiol. Dis. | pmid:23607938 |
| Venojärvi M et al. | 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. | 2013 | Food Chem. Toxicol. | pmid:23623841 |
| Hoy J et al. | Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. | 2013 | J. Bone Miner. Res. | pmid:23299909 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Yassuda DH et al. | Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. | 2013 | J Biomed Mater Res A | pmid:23239606 |
| Gao L et al. | Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. | 2013 | J. Immunol. | pmid:23241890 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Kim SJ et al. | Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. | 2013 | Arch. Oral Biol. | pmid:23219295 |
| Kanzaki H et al. | Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. | 2013 | Exp. Mol. Pathol. | pmid:23219833 |
| Wang H et al. | Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. | 2013 | Gene Ther. | pmid:22318091 |
| Gümüş P et al. | Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. | 2013 | J. Periodontol. | pmid:23327689 |
| Rosenheck S | The heart and the osteoclasts. | 2013 | Cardiology | pmid:23328209 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Frederiksen L et al. | Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. | 2013 | Horm. Metab. Res. | pmid:22918704 |
| Hartwich JE et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. | 2013 | J. Pediatr. Surg. | pmid:23331792 |
| Naidu VG et al. | RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. | 2013 | Chem. Biol. Interact. | pmid:23333834 |
| Zhang Q et al. | Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. | 2013 | ScientificWorldJournal | pmid:24222748 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Luo ZR et al. | [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. | 2013 | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | pmid:24225213 |
| Zhang F et al. | Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. | 2013 | Med. Oncol. | pmid:23335067 |
| Su SJ et al. | Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. | 2013 | Int J Food Sci Nutr | pmid:23301724 |
| Aoki A et al. | Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. | 2013 | Cardiovasc Diabetol | pmid:23302066 |
| Pathan E et al. | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. | 2013 | Ann. Rheum. Dis. | pmid:22984171 |
| Guerra-Menéndez L et al. | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | 2013 | J Transl Med | pmid:24161214 |
| MacNee W | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. | 2013 | Ann. Med. | pmid:23110517 |
| Montagnana M et al. | The role of osteoprotegerin in cardiovascular disease. | 2013 | Ann. Med. | pmid:23110639 |
| Romagnoli C et al. | Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. | 2013 | FEBS J. | pmid:23176170 |
| Kadkhodazadeh M et al. | Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. | 2013 | Arch. Oral Biol. | pmid:23177932 |
| Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
| Mercatali L et al. | RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. | 2013 | Int J Mol Sci | pmid:23702841 |
| Braun T et al. | Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. | 2013 | J. Bone Miner. Res. | pmid:23169443 |
| Bosselut N et al. | Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. | 2013 | Clin. Chim. Acta | pmid:23022619 |
| Tousoulis D et al. | Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. | 2013 | Int. J. Cardiol. | pmid:22640692 |
| Rivadeneira F | Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. | 2013 | Endocrine | pmid:23001603 |
| Scott JP et al. | Effect of recovery duration between two bouts of running on bone metabolism. | 2013 | Med Sci Sports Exerc | pmid:23034642 |